CKD-702 Plus Irinotecan in Gastric Cancer
Clinical trial NCT05750290 · UNKNOWN
Trial details
- NCT number
- NCT05750290
- Sponsor
- National Cancer Center, Korea
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.